Fiverr International Ltd (FVRR) Stock Price Today
Aura AI Summary
Key Stats
- $324.28MMarket Cap
- -Volume
- IndustrialsSector
- $26.6752W High
- $8.6652W Low
- -Typical Hold Time
- $76.66MEnterprise Value
- -Div Yield
- -Trading Activity
Track Fiverr International Ltd (FVRR) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Fiverr International Ltd has traded between a low of $8.66 and a high of $26.67, highlighting its annual price range. Buy and sell Fiverr International Ltd shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Most Recent News
Airbus leads aerospace market with strong orders despite production challenges
Airbus is outperforming Boeing in commercial aircraft orders, securing 821 net orders in H1 2026 compared to Boeing's 408. Morgan Stanley maintains an "Overweight" rating on Airbus, raising its price target to €255, reflecting confidence in the compa...
Applied Materials stock dips post-earnings despite strong results and raised price target to $700.
Applied Materials reported strong Q3 financial results with revenue up 25% to $9.12 billion and adjusted EPS rising 41% to $3.50, beating Wall Street estimates. However, the stock fell over 5% after earnings due to market expectations being even high...
Ascendis Pharma posts strong Q2 2026 with €339M revenue, boosts price target to $290 by RBC Capital.
Ascendis Pharma reported robust Q2 2026 results with total revenue of €339 million, driven by strong sales of its three main products: YORVIPATH®, SKYTROFA®, and YUVIWEL®. The company achieved a net profit of €207 million and ended the quarter with a...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.